Mijia Wu - 21 May 2022 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Director
Signature
/s/ Justin Hall as attorney in fact for Mijia Wu
Issuer symbol
NBY
Transactions as of
21 May 2022
Net transactions value
$0
Form type
4
Filing time
24 May 2022, 19:33:20 UTC
Previous filing
13 May 2022
Next filing
15 May 2023
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Mijia Wu filed Form 4 for NovaBay Pharmaceuticals, Inc. (NBY) on 24 May 2022."

Quick Takeaways

  • This page summarizes Mijia Wu's Form 4 filing for NovaBay Pharmaceuticals, Inc. (NBY).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 24 May 2022, 19:33.

What Changed

  • Previous filing in this sequence was filed on 13 May 2022.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock Options Exercise +30,000 30,000 21 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBY Restricted Stock Units Options Exercise $0 -30,000 -50% $0.000000 30,000 21 May 2022 Common Stock 30,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.

Sponsored